Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality

BACKGROUND AND AIMS: High levels of lipoprotein(a) could worsen the outcome of COVID-19 due to prothrombotic and proinflammatory properties of lipoprotein(a). We tested the hypotheses that during COVID-19 hospitalization i) increased thrombotic activity and inflammation are associated with lipoprote...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaltoft, Morten, Glavind, Kathrine Sofia, Nielsen, Sune Fallgaard, Langsted, Anne, Iversen, Kasper Karmark, Nordestgaard, Børge Grønne, Kamstrup, Pia Rørbæk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343714/
https://www.ncbi.nlm.nih.gov/pubmed/36037760
http://dx.doi.org/10.1016/j.atherosclerosis.2022.07.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343714/
https://www.ncbi.nlm.nih.gov/pubmed/36037760
http://dx.doi.org/10.1016/j.atherosclerosis.2022.07.015

Ejemplares similares